What are some of the department’s most satisfying successes of the past year and why?

It’s difficult to answer this question without “leaving out” a tremendous victory. Our standout wins involve incredible advances like the molecule behind Ozempic, Wegovy and Rybelsus, the COVID-19 vaccine, and a radical advance in genome sequencing technology. We also had massive appellate wins for Genentech and Tristar on the issues of enablement and inventorship, respectively.